Skip to main content
Premium Trial:

Request an Annual Quote

InforMax, AxCell Finalize Bioinformatics Alliance for Proteomics Database


PRINCETON, NJ--AxCell Biosciences, a wholly owned subsidiary of Cytogen based here, and InforMax of Rockville, Md., have signed a final agreement to market a proprietary proteomics database that AxCell is developing, as part of an enterprise bioinformatics system to the pharmaceutical, biotechnology, and agricultural industries. As part of the multi-year agreement, InforMax will link AxCell's database to its Software Solution for BioMedicine enterprise bioinformatics system and lead the marketing effort in exchange for a royalty payment on sales. The two companies will initially concentrate on an early-subscriber program for pharmaceutical organizations interested in early access to the data.

Separately, InforMax has launched new versions of its software, Vector NTI Suite 5.5 for desktop sequence analysis and SSBM 2.0, both of which have new features and functions designed to increase productivity of researchers.

Filed under

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.